Targeting the TGFβ pathway for cancer therapy

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• The TGFβ signaling pathway regulates critical cellular functions including growth, differentiation, apoptosis, and immune response.
• Deregulation of TGFβ signaling is common in tumors, playing roles in initiation, development, and metastasis.
• TGFβ's dual role as a tumor promoter or suppressor at the cancer cell level is debated, but it consistently favors tumor growth in the microenvironment.

Purpose of the Study:

• To review the multifaceted roles of the TGFβ pathway in cancer, focusing on both cancer cells and the tumor microenvironment.
• To summarize preclinical and clinical findings of TGFβ pathway inhibition as a cancer therapy.
• To explore future perspectives for optimizing TGFβ inhibition strategies in various cancer types.

Main Methods:

• Comprehensive literature review of TGFβ signaling in cancer.
• Analysis of preclinical and clinical data on TGFβ pathway inhibitors.
• Evaluation of the impact of TGFβ inhibition on the tumor microenvironment.

Main Results:

• TGFβ signaling consistently promotes a tumor-supportive microenvironment throughout carcinogenesis.
• Targeting the TGFβ pathway is primarily viewed as a microenvironment-targeted strategy.
• Pharmacological inhibition strategies show promise, with notable effects on the tumor microenvironment.

Conclusions:

• TGFβ pathway inhibition represents a promising therapeutic avenue, particularly for its effects on the tumor microenvironment.
• Further research is needed to optimize TGFβ inhibition therapies for diverse tumor settings.
• Understanding TGFβ's complex roles is key to developing effective cancer treatments.